Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

Conditions: Colorectal Cancer Interventions: Drug: Tislelizumab with Fruquintinib, Metronidazole Sponsors: Jing-yuan Fang, MD, Ph. D Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials